COLLINS Asha
Known title: DirectorCIK: 0001832272
Associated companies
Transaction History
| IDXX | ▲ Buy | Option Exercise | 257 | $0 | 5/6/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 344 | $0 | 5/11/2023 | View on chart |
| IDXX | ▲ Buy | Grant | 41 | $20K | 1/28/2022 | View on chart |
| IDXX | ▲ Buy | Grant | 30 | $20K | 10/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KeyBanc initiates IDEXX coverage with Sector Weight rating
KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.
KeyBanc initiates IDEXX coverage with Sector Weight rating. KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.